Platelets, chromogranin A and C-reactive protein predict therapy failure of metastatic hormone-sensitive prostate cancer while miR-375 outperforms PSA in stratifying castration-resistant prostate cancer

CHRENKOVA, E., R. SPURNA, K. HOLA, J. VRBKOVÁ, J. KNILLOVÁ, M. LEVKOVÁ, H. ŠTUDENTOVÁ, J. BOUCHAL
Platelets, chromogranin A and C-reactive protein predict therapy failure of metastatic hormone-sensitive prostate cancer while miR-375 outperforms PSA in stratifying castration-resistant prostate cancer. The Journal of Molecular Diagnostics : JMD. 2025, S1525-1578(25), 00063-7, ISSN: 1525-1578, PMID: 40139458,